All Pharma News
VBI Vaccines Reports Full Year 2023 Financial Results

VBI Vaccines Reports Full Year 2023 Financial Results
BUSINESSWIRE
16 Apr 2024
Share Share
VBI $2M Registered Direct Offering Per Nasdaq

VBI $2M Registered Direct Offering Per Nasdaq
BUSINESSWIRE
11 Apr 2024
Share Share
VBI Vaccines Announces $2M Direct Offering

VBI Vaccines Announces $2M Direct Offering
BUSINESSWIRE
09 Apr 2024
Share Share
VBI Announces Strategic Partnership with Canadian Govt to for Vaccine Platform

VBI Announces Strategic Partnership with Canadian Govt to for Vaccine Platform
BUSINESSWIRE
02 Apr 2024
Share Share
VBI Vaccines shrinks `long-term burn` with $33M Brii Bio deal

VBI Vaccines shrinks `long-term burn` with $33M Brii Bio deal
FIERCE PHARMA
14 Feb 2024
Share Share
VBI Vaccines Presents Biomarker Data from Phase 1/2a Study of VBI-1901

VBI Vaccines Presents Biomarker Data from Phase 1/2a Study of VBI-1901
BUSINESSWIRE
20 Nov 2023
Share Share
VBI Vaccines Reports Third Quarter 2023 Financial Results

VBI Vaccines Reports Third Quarter 2023 Financial Results
BUSINESSWIRE
14 Nov 2023
Share Share
VBI Vaccines Expands Proprietary Technology Platforms

VBI Vaccines Expands Proprietary Technology Platforms
BUSINESSWIRE
26 Oct 2023
Share Share
VBI Vaccines’ Pan-Coronavirus Vaccine Candidate, VBI-2901

VBI Vaccines’ Pan-Coronavirus Vaccine Candidate, VBI-2901
BUSINESSWIRE
27 Sep 2023
Share Share
VBI Vaccines Announces Dosing of First Patients in Phase 2b Study of VBI-1901

VBI Vaccines Announces Dosing of First Patients in Phase 2b Study of VBI-1901
BUSINESSWIRE
07 Sep 2023
Share Share